TY - STD TI - Association for Molecular Pathology v. U.S. Patent and Trademark Office, 702 F. Supp. 2d 181 (S.D.N.Y. 2010). ID - ref1 ER - TY - CHAP AU - Vorhaus, J. C. a. D. ED - Vorhaus, D. PY - 2010 DA - 2010// TI - Pigs Fly: Federal Court Invalidates Myriad's Patent Claims BT - The Genomics Law Report PB - Hinson CY - PA ID - Vorhaus2010 ER - TY - STD TI - Association for Molecular Pathology v. U.S. Patent and Trademark Office, 653 F.3d 1329 (Fed. Cir. 2011). ID - ref3 ER - TY - STD TI - Petition for Writ of Certiorari, Ass'n for Molecular Pathology v. Myriad Genetics, Inc., No. 12-398, (U.S. Sept. 25, 2012). ID - ref4 ER - TY - STD TI - Docket Files for Association of Molecular Pathology, et al. v. Myriad Genetics Inc., et al. [http://www.supremecourt.gov/Search.aspx?FileName=/docketfiles/11-725.htm] UR - http://www.supremecourt.gov/Search.aspx?FileName=/docketfiles/11-725.htm ID - ref5 ER - TY - STD TI - Docket Files for the Association of Molecular Pathology et al. v. Myriad Genetics Inc., et al. [http://www.supremecourt.gov/Search.aspx?FileName=/docketfiles/12-398.htm] UR - http://www.supremecourt.gov/Search.aspx?FileName=/docketfiles/12-398.htm ID - ref6 ER - TY - JOUR AU - Eisenberg, R. PY - 2002 DA - 2002// TI - How can you patent genes? JO - American Journal of Bioethics VL - 2 UR - https://doi.org/10.1162/152651602760249969 DO - 10.1162/152651602760249969 ID - Eisenberg2002 ER - TY - CHAP AU - Parthasarathy, S. PY - 2007 DA - 2007// BT - Building Genetic Medicine: Breast Cancer, Technology, and the Comparative Politics of Healthcare PB - MIT Press CY - Cambridge, MA ID - Parthasarathy2007 ER - TY - JOUR AU - Gold, E. R. AU - Carbone, J. PY - 2010 DA - 2010// TI - Myriad Genetics: In the eye of the policy storm JO - Genetics in medicine: official journal of the American College of Medical Genetics VL - 12 UR - https://doi.org/10.1097/GIM.0b013e3181d72661 DO - 10.1097/GIM.0b013e3181d72661 ID - Gold2010 ER - TY - CHAP AU - Davies, K. AU - White, M. PY - 1996 DA - 1996// BT - Breakthrough: the race to find the breast cancer gene ID - Davies1996 ER - TY - JOUR AU - Williams-Jones, B. PY - 2002 DA - 2002// TI - History of a gene patent: tracing the development and application of commercial BRCA testing JO - Health Law Journal VL - 10 ID - Williams-Jones2002 ER - TY - JOUR AU - Caulfield, T. AU - Cook-Deegan, R. M. AU - Kieff, F. S. AU - Walsh, J. P. PY - 2006 DA - 2006// TI - Evidence and anecdotes: an analysis of human gene patenting controversies JO - Nat Biotechnol VL - 24 UR - https://doi.org/10.1038/nbt0906-1091 DO - 10.1038/nbt0906-1091 ID - Caulfield2006 ER - TY - JOUR AU - Caulfield, T. AU - Bubela, T. AU - Murdoch, C. J. PY - 2007 DA - 2007// TI - Myriad and the mass media: the covering of a gene patent controversy JO - Genet Med VL - 9 UR - https://doi.org/10.1097/GIM.0b013e31815bf965 DO - 10.1097/GIM.0b013e31815bf965 ID - Caulfield2007 ER - TY - STD TI - Genentech and Chairman/CEO Levinson to Receive National Breast Cancer Coalition's Corporate Leadership Award. [http://www.gene.com/gene/news/press-releases/display.do?method=detail&id=4890] UR - http://www.gene.com/gene/news/press-releases/display.do?method=detail&id=4890 ID - ref14 ER - TY - JOUR AU - Gusella, J. F. AU - Wexler, N. S. AU - Conneally, P. M. AU - Naylor, S. L. AU - Anderson, M. A. AU - Tanzi, R. E. AU - Watkins, P. C. AU - Ottina, K. AU - Wallace, M. R. AU - Sakaguchi, A. Y. PY - 1983 DA - 1983// TI - A polymorphic DNA marker genetically linked to Huntington's disease JO - Nature VL - 306 UR - https://doi.org/10.1038/306234a0 DO - 10.1038/306234a0 ID - Gusella1983 ER - TY - JOUR AU - Stephens, J. C. AU - Mador, M. L. AU - Cavanaugh, M. L. AU - Gradie, M. I. AU - Kidd, K. K. PY - 1990 DA - 1990// TI - Mapping the Human Genome: Current Status JO - Science VL - 250 UR - https://doi.org/10.1126/science.2218527 DO - 10.1126/science.2218527 ID - Stephens1990 ER - TY - JOUR AU - Roberts, L. PY - 1991 DA - 1991// TI - The rush to publish JO - Science VL - 251 UR - https://doi.org/10.1126/science.1898994 DO - 10.1126/science.1898994 ID - Roberts1991 ER - TY - JOUR AU - Wooster, R. AU - Neuhausen, S. L. AU - Mangion, J. AU - Quirk, Y. AU - Ford, D. AU - Collins, N. AU - Nguyen, K. AU - Seal, S. AU - Tran, T. AU - Averill, D. PY - 1994 DA - 1994// TI - Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13 JO - Science VL - 265 UR - https://doi.org/10.1126/science.8091231 DO - 10.1126/science.8091231 ID - Wooster1994 ER - TY - JOUR AU - Wooster, R. AU - Bignell, G. AU - Lancaster, J. AU - Swift, S. AU - Seal, S. AU - Mangion, J. AU - Collins, N. AU - Gregory, S. AU - Gumbs, C. AU - Micklem, G. PY - 1995 DA - 1995// TI - Identification of the breast cancer susceptibility gene BRCA2 JO - Nature VL - 378 UR - https://doi.org/10.1038/378789a0 DO - 10.1038/378789a0 ID - Wooster1995 ER - TY - JOUR AU - Tavtigian, S. V. AU - Simard, J. AU - Rommens, J. AU - Couch, F. AU - Shattuck-Eidens, D. AU - Neuhausen, S. AU - Merajver, S. AU - Thorlacius, S. AU - Offit, K. AU - Stoppa-Lyonnet, D. PY - 1996 DA - 1996// TI - The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds JO - Nature genetics VL - 12 UR - https://doi.org/10.1038/ng0396-333 DO - 10.1038/ng0396-333 ID - Tavtigian1996 ER - TY - STD TI - Tavtigian et al. Chromosome 13-Linked Breast Cancer Susceptibility Gene. US Patent 6,033,857. Filed March 20, 1998 and issued March 7, 2000. ID - ref21 ER - TY - STD TI - A. Futreal et al. Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof. US Patent 6,045,997. Filed November 25, 1996 and issued April 4, 2000. ID - ref22 ER - TY - STD TI - D. Shattuck-Eidens, et al. Linked Breast and Ovarian Cancer Susceptibility Gene. US Patent 5,693,473. Filed June 7, 1995 and issued December 2, 1997. In ID - ref23 ER - TY - JOUR AU - Cook-Deegan, R. AU - DeRienzo, C. AU - Carbone, J. AU - Chandrasekharan, S. AU - Heaney, C. AU - Conover, C. PY - 2010 DA - 2010// TI - Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: comparing breast and ovarian cancers with colon cancers JO - Genet Med VL - 12 UR - https://doi.org/10.1097/GIM.0b013e3181d5a67b DO - 10.1097/GIM.0b013e3181d5a67b ID - Cook-Deegan2010 ER - TY - STD TI - BRACAnalysis. [http://www.bracnow.com/] UR - http://www.bracnow.com/ ID - ref25 ER - TY - JOUR AU - Fisher, B. AU - Costantino, J. P. AU - Wickerham, D. L. AU - Redmond, C. K. AU - Kavanah, M. AU - Cronin, W. M. AU - Vogel, V. AU - Robidoux, A. AU - Dimitrov, N. AU - Atkins, J. PY - 1998 DA - 1998// TI - Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study JO - Journal of the National Cancer Institute VL - 90 UR - https://doi.org/10.1093/jnci/90.18.1371 DO - 10.1093/jnci/90.18.1371 ID - Fisher1998 ER - TY - JOUR AU - Kauff, N. D. AU - Satagopan, J. M. AU - Robson, M. E. AU - Scheuer, L. AU - Hensley, M. AU - Hudis, C. A. AU - Ellis, N. A. AU - Boyd, J. AU - Borgen, P. I. AU - Barakat, R. R. PY - 2002 DA - 2002// TI - Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation JO - The New England journal of medicine VL - 346 UR - https://doi.org/10.1056/NEJMoa020119 DO - 10.1056/NEJMoa020119 ID - Kauff2002 ER - TY - CHAP AU - John Conley, D. V. AU - Robert, C. o. o. k. -. D. e. e. g. a. n. ED - Vorhaus, D. PY - 2011 DA - 2011// TI - How Will Myriad Respond to the Next Generation of BRCA Testing? BT - Genomics Law Report ID - John Conley2011 ER - TY - CHAP PY - 2012 DA - 2012// BT - Myriad Genetics SEC Annual Report, Form 10-K PB - United States Securities and Exchange Commission CY - Washington, D.C. ID - ref29 ER - TY - CHAP AU - Bazell, R. PY - 1998 DA - 1998// BT - Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer ID - Bazell1998 ER - TY - JOUR AU - Slamon, D. J. AU - Godolphin, W. AU - Jones, L. A. AU - Holt, J. A. AU - Wong, S. G. AU - Keith, D. E. AU - Levin, W. J. AU - Stuart, S. G. AU - Udove, J. AU - Ullrich, A. PY - 1989 DA - 1989// TI - Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer JO - Science VL - 244 UR - https://doi.org/10.1126/science.2470152 DO - 10.1126/science.2470152 ID - Slamon1989 ER - TY - CHAP AU - Szabo, L. PY - 2008 DA - 2008// TI - Breakout drug Herceptin brings new age in breast cancer care BT - USA Today ID - Szabo2008 ER - TY - JOUR AU - Piccart-Gebhart, M. J. AU - Procter, M. AU - Leyland-Jones, B. AU - Goldhirsch, A. AU - Untch, M. AU - Smith, I. AU - Gianni, L. AU - Baselga, J. AU - Bell, R. AU - Jackisch, C. PY - 2005 DA - 2005// TI - Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer JO - The New England journal of medicine VL - 353 UR - https://doi.org/10.1056/NEJMoa052306 DO - 10.1056/NEJMoa052306 ID - Piccart-Gebhart2005 ER - TY - STD TI - Genentech Announces Full Year and Fourth Quarter 2008 Results. [http://www.sec.gov/Archives/edgar/data/318771/000031877109000002/ex99_1.htm] UR - http://www.sec.gov/Archives/edgar/data/318771/000031877109000002/ex99_1.htm ID - ref34 ER - TY - CHAP AU - Bosklopper, E. PY - 2012 DA - 2012// BT - Antibody Drugs: Technologies and Global Markets PB - BCC Research CY - Wellesley, MA ID - Bosklopper2012 ER - TY - STD TI - Association for Molecular Pathology v. U.S. Patent and Trademark Office, 702 F. Supp. 2d 181 (S.D.N.Y. 2010). Declaration of Arupa Ganguly, Ph.D. [http://www.aclu.org/files/pdfs/freespeech/brca_Ganguly_declaration_20090826.pdf] UR - http://www.aclu.org/files/pdfs/freespeech/brca_Ganguly_declaration_20090826.pdf ID - ref36 ER - TY - CHAP PY - 1999 DA - 1999// BT - Memorandum of Understanding between Myriad Genetics, Inc. And the National Cancer Institute PB - Myriad Genetics and the National Cancer Institute CY - Salt Lake City, UT ID - ref37 ER - TY - JOUR AU - Eisenberg, R. PY - 1996 DA - 1996// TI - Public Research and Private Development: Patents and Technology Transfer in Government-Sponsored Research JO - Virginia Law Review VL - 82 UR - https://doi.org/10.2307/1073686 DO - 10.2307/1073686 ID - Eisenberg1996 ER - TY - JOUR AU - Mueller, J. PY - 2004 DA - 2004// TI - The Evanescent Experimental Use Exemption from the United States Patent Infringement Liability: Implications for University and Nonprofit Research and Development JO - Baylor Law Review VL - 56 ID - Mueller2004 ER - TY - STD TI - Twitter report from the Genomes, Environments, Traits (GET) Conference, Boston, MA, April 27, 2010. [http://www.genomicslawreport.com/wp-content/plugins/as-pdf/generate.php?post=3231] UR - http://www.genomicslawreport.com/wp-content/plugins/as-pdf/generate.php?post=3231 ID - ref40 ER - TY - CHAP AU - Rebecca Farkas, D. G. AU - Margaret, E. a. t. o. n. PY - 2004 DA - 2004// BT - Myriad and OncorMed and the marketing of the first genetic tests for breast cancer susceptibility PB - Stanford Graduate School of Business CY - Palo Alto, California ID - Rebecca Farkas2004 ER - TY - JOUR AU - Cho, M. K. AU - Illangasekare, S. AU - Weaver, M. A. AU - Leonard, D. G. AU - Merz, J. F. PY - 2003 DA - 2003// TI - Effects of patents and licenses on the provision of clinical genetic testing services JO - J Mol Diagn VL - 5 UR - https://doi.org/10.1016/S1525-1578(10)60444-8 DO - 10.1016/S1525-1578(10)60444-8 ID - Cho2003 ER - TY - CHAP AU - Friedman, S. PY - 2012 DA - 2012// BT - Testimony to USPTO on impact of exclusive gene patents ID - Friedman2012 ER - TY - STD TI - An Open Access On-Line Breast Cancer Mutation Data Base. [http://research.nhgri.nih.gov/bic/] UR - http://research.nhgri.nih.gov/bic/ ID - ref44 ER - TY - CHAP AU - Cook-Deegan, R. AU - Conley, J. M. AU - Evans, J. P. AU - Vorhaus, D. PY - 2012 DA - 2012// TI - The next controversy in genetic testing: clinical data as trade secrets? BT - European journal of human genetics: EJHG ID - Cook-Deegan2012 ER - TY - STD TI - USPTO Roundtable Written Commentary. [http://www.facingourrisk.org/advocacy/current_action/documents/USPTO_Jan2013_Written_Testimony.pdf] UR - http://www.facingourrisk.org/advocacy/current_action/documents/USPTO_Jan2013_Written_Testimony.pdf ID - ref46 ER - TY - JOUR AU - Azvolinsky, A. PY - 2012 DA - 2012// TI - Lack of BRCA testing approval creates snag for cancer trials JO - Nature medicine VL - 18 UR - https://doi.org/10.1038/nm0912-1310a DO - 10.1038/nm0912-1310a ID - Azvolinsky2012 ER - TY - STD TI - Testimony to USPTO on impact on exclusive gene patents. [http://www.facingourrisk.org/advocacy/current_action/uspto_update.php] UR - http://www.facingourrisk.org/advocacy/current_action/uspto_update.php ID - ref48 ER - TY - CHAP AU - Elizabeth Swisher, M. PY - 2009 DA - 2009// BT - Association for Molecular Pathology v. U.S. Patent and Trademark Office, 702 F. Supp. 2d 181 (S.D.N.Y. 2010).Declaration of Elizabeth Swisher, MD ID - Elizabeth Swisher2009 ER - TY - JOUR AU - Palma, M. D. AU - Domchek, S. M. AU - Stopfer, J. AU - Erlichman, J. AU - Siegfried, J. D. AU - Tigges-Cardwell, J. AU - Mason, B. A. AU - Rebbeck, T. R. AU - Nathanson, K. L. PY - 2008 DA - 2008// TI - The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families JO - Cancer research VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-08-0599 DO - 10.1158/0008-5472.CAN-08-0599 ID - Palma2008 ER - TY - CHAP AU - Ellen Matloff, R. B. AU - Danielle, B. o. n. a. d. i. e. s. ED - Richard Wenstrup, M. PY - 2011 DA - 2011// BT - An Open Letter to Myriad Genetics PB - Yale Cancer Genetic Counseling CY - New Haven, Connecticut ID - Ellen Matloff2011 ER - TY - CHAP AU - Cohen, E. PY - 2011 DA - 2011// BT - When breast cancer test gets it wrong PB - CNN CY - CNN Health ID - Cohen2011 ER - TY - STD TI - NBCC Responds to ODAC Vote on AvastinĀ®. [http://www.knowbreastcancer.org/news-research/news/nbcc-response-to-odac-vote-on.html] UR - http://www.knowbreastcancer.org/news-research/news/nbcc-response-to-odac-vote-on.html ID - ref53 ER - TY - STD TI - Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 1996, 14: 1730-1736. discussion 1737-1740 ID - ref54 ER - TY - CHAP ED - Oncology, A. S. o. C. PY - 1996 DA - 1996// BT - Commentary on the ASCO Statement on Genetic Testing for Cancer Susceptibility ID - ref55 ER - TY - JOUR AU - Walsh, T. AU - Lee, M. K. AU - Casadei, S. AU - Thornton, A. M. AU - Stray, S. M. AU - Pennil, C. AU - Nord, A. S. AU - Mandell, J. B. AU - Swisher, E. M. AU - King, M. C. PY - 2010 DA - 2010// TI - Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing JO - Proceedings of the National Academy of Sciences of the United States of America VL - 107 UR - https://doi.org/10.1073/pnas.1007983107 DO - 10.1073/pnas.1007983107 ID - Walsh2010 ER - TY - JOUR AU - Kepler, T. B. AU - Crossman, C. AU - Cook-Deegan, R. PY - 2010 DA - 2010// TI - Metastasizing patent claims on BRCA1 JO - Genomics VL - 95 UR - https://doi.org/10.1016/j.ygeno.2010.03.003 DO - 10.1016/j.ygeno.2010.03.003 ID - Kepler2010 ER - TY - CHAP AU - Scholl PY - 2011 DA - 2011// BT - BRCA2 Mutations and Use Thereof, US Patent 7,993,835 PB - Myriad Genetics, Inc. CY - Issued by United States Patent and Trade Office. USA ID - Scholl2011 ER - TY - CHAP AU - Robert Cook-Deegan, J. C. AU - James, E. v. a. n. s. AU - Daniel, V. o. r. h. a. u. s. PY - 2012 DA - 2012// TI - The Next Controvery in Genetic Testing: Clinical Data as Trade Secrets? BT - European Journal of Human Genetics ID - Robert Cook-Deegan2012 ER - TY - STD TI - What Happened at the Fda Avastin Meeting?. [http://www.clinicaloncology.com/ViewArticle.aspx?d=Solid+Tumors&d_id=148&i=August+2011&i_id=757&a_id=18820.%5D] UR - http://www.clinicaloncology.com/ViewArticle.aspx?d=Solid+Tumors&d_id=148&i=August+2011&i_id=757&a_id=18820.%5D ID - ref60 ER - TY - CHAP AU - Linn, A. PY - 1995 DA - 1995// TI - As They Lay Dying BT - San Francisco Weekly PB - Village Voice Media Holdings, LLC CY - San Francisco ID - Linn1995 ER - TY - STD TI - NBCC President Praises Genentech for Partnering With Breast Cancer Advocates in HER-2 Trial. [http://www.cancernetwork.com/display/article/10165/64743] UR - http://www.cancernetwork.com/display/article/10165/64743 ID - ref62 ER - TY - STD TI - Comment 43: National Breast Cancer Coalition/Fran Visco. [http://www.uspto.gov/web/offices/com/sol/comments/utilguide/nbcc.pdf] UR - http://www.uspto.gov/web/offices/com/sol/comments/utilguide/nbcc.pdf ID - ref63 ER - TY - STD TI - Association for Molecular Pathology v. U.S. Patent and Trademark Office, 702 F. Supp. 2d 181 (S.D.N.Y. 2010).Declaration of Dr. Mark Skolnick. [http://docs.justia.com/cases/federal/district-courts/new-york/nysdce/1:2009cv04515/345544/172/0.pdf?ts=1262043961] UR - http://docs.justia.com/cases/federal/district-courts/new-york/nysdce/1:2009cv04515/345544/172/0.pdf?ts=1262043961 ID - ref64 ER - TY - STD TI - Take Back Your Genes | American Civil Liberties Union. [http://www.aclu.org/take-back-your-genes] UR - http://www.aclu.org/take-back-your-genes ID - ref65 ER - TY - BOOK AU - Watson, J. a. m. e. s. PY - 2012 DA - 2012// TI - Brief for Amicus Curiae James D. Watson in Support of Neither Party ID - Watson2012 ER - TY - JOUR AU - Lenzer, J. AU - Brownlee, S. PY - 2008 DA - 2008// TI - Naming names: is there an (unbiased) doctor in the house? JO - BMJ VL - 337 UR - https://doi.org/10.1136/bmj.a930 DO - 10.1136/bmj.a930 ID - Lenzer2008 ER -